Publikace
Počet publikací: 2
Články
-
Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes
The British journal of ophthalmology : incorporating the Royal London ophthalmic hospital reports, the Ophthalmic review and the Ophthalmoscope, rok: 2023, ročník: 107, vydání: 3, DOI
-
Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic
European Journal of Ophthalmology, rok: 2023, DOI